Terms ending in 2028
Every in-force patent on Chemocentryx, Inc.'s record whose computed term ends in 2028, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 7,718,683 | Triazolyl Phenyl Benzenesulfonamides In force · High confidence | Chemocentryx, Inc. | In force | High confidence | |
| US 7,786,157 | Oxo-Imidazolidines as Modulators of Chemokine Receptors In force · High confidence | Chemocentryx, Inc. | In force | High confidence | |
| US 7,629,344 | 3-(Imidazolyl)-pyrazolo[3,4-b]pyridines In force · High confidence | Chemocentryx, Inc. | In force | High confidence | |
| US 9,409,909 | N-(2-(HETARYL)ARYL)ARYLSULFONAMIDES and N-(2-(HETARYL)HETARYL)ARYLSULFONAMIDES In force · Medium confidence | ChemoCentryx, Inc. | In force | Medium confidence | |
| US 8,546,408 | Fused Heteroaryl Pyridyl and Phenyl Benzenesuflonamides as CCR2 Modulators for the Treatment of Inflammation In force · High confidence | Chemocentryx, Inc. | In force | High confidence | |
| US 9,394,307 | Fused Heteroaryl Pyridyl and Phenyl Benzenesuflonamides as CCR2 Modulators for the Treatment of Inflammation In force · High confidence | Chemocentryx, Inc. | In force | High confidence | |
| US 9,745,312 | Fused Heteroaryl Pyridyl and Phenyl Benzenesuflonamides as CCR2 Modulators for the Treatment of Inflammation In force · High confidence | ChemoCentryx, Inc. | In force | High confidence | |
| US 10,208,050 | Fused Heteroaryl Pyridyl and Phenyl Benzenesuflonamides as CCR2 Modulators for the Treatment of Inflammation In force · High confidence | Chemocentryx, Inc. | In force | High confidence | |
| US 10,899,765 | Fused Heteroaryl Pyridyl and Phenyl Benzenesuflonamides as CCR2 Modulators for the Treatment of Inflammation In force · High confidence | Chemocentryx, Inc. | In force | High confidence | |
| US 8,445,518 | Triazolyl Pyridyl Benzenesulfonamides In force · High confidence | Chemocentryx, Inc. | In force | High confidence | |
| 1 more term end in 2028 · Pro | |||||
10 of 11 patents shown. Soonest term end first, then patent number.
Pro members see all 11, including 2 expiring within the 18 months from Nov 21, 2026.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.